Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells

Cancer Research

Volumn 62, Issue 24, 2002, Pages 7328-7334

  Murakami, Takashi ^a   Maki, Wusi ^a   Cardones, Adela R ^a   Fang, Hui ^a   Tun Kyi, Adrian ^b   Nestle, Frank O ^b   Hwang, Sam T ^a,c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c Building 10 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR4; RECEPTOR BLOCKING AGENT;

ANIMAL CELL; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KIDNEY METASTASIS; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

AMINO ACID SEQUENCE; ANIMALS; CELL ADHESION; CELL DIVISION; CHEMOKINES, CXC; ENDOTHELIUM, VASCULAR; FEMALE; LUCIFERASES; LUNG NEOPLASMS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; RECEPTORS, CXCR4; SKIN NEOPLASMS; TRANSDUCTION, GENETIC;

EID: 0037115647     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Coit, D. G., Rogatko, A., and Brennan, M. F. Prognostic factors in patients with melanoma metastatic to axillary or inguinal lymph nodes. A multivariate analysis. Ann. Surg., 214: 627-636, 1991.
2. Hart, I. R., and Fidler, I. J. Role of organ selectivity in the determination of metastatic patterns of B16 melanoma. Cancer Res., 40: 2281-2287, 1980.
3. Cohn-Cedermark, G., Mansson-Brahme, E., Rutqvist, L. E., Larsson, O., Singnomklao, T., and Ringborg, U. Metastatic patterns, clinical outcome, and malignant phenotype in malignant cutaneous melanoma. Acta Oncol., 38: 549-557, 1999.
4. Clark, E. A., Golub, T. R., Lander, E. S., and Hynes, R. O. Genomic analysis of metastasis reveals an essential rote for RhoC. Nature (Lond.), 406: 532-535, 2000.
5. Skobe, M., Hawighorst, T., Jackson, D. G., Prevo, R., Janes, L., Velasco, P., Riccardi. L., Alitalo, K., Claffey, K., and Detmar, M. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat. Med., 7: 192-198, 2001.
6. Stacker. S. A., Caesar, C., Baldwin, M. E., Thornton, G. E., Williams, R. A., Prevo. R., Jackson, D. G., Nishikawa Si, S., Kubo, H., and Achen, M. G. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat. Med., 7: 186-191, 2001.
7. Woodhouse. E. C., Chuaqui, R. F., and Liotta. L. A. General mechanisms of metastasis. Cancer (Phila.), 80: 1529-1537, 1997.
8. Müller. A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., Barrera, J. L., Mohar, A., Verástegul, E., and Zlotnik, A. Involvement of chemokine receptors in breast cancer metastasis. Nature (Lond.), 410: 50-56, 2001.
9. Gunn, M. D., Kyuwa, S., Tam, C., Kakiuchi, T., Matsuzawa, A., Williams, L. T., and Nakano, H. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization [see comments]. J. Exp. Med., 189: 451-460, 1999.
10. Saeki, H., Moore, A. M., Brown, M. J., and Hwang, S. T. Cutting edge: Secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. J. Immunol., 162: 2472-2475, 1999.
11. Förster, R., Schubel, A., Breitfeld, D., Kremmer, E., Renner-Muller, I., Wolf, E., and Lipp, M. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell, 99: 23-33, 1999.
12. Engeman. T. M., Gorbachev, A. V., Gladue, R. P., Heeger, P. S., and Fairchild, R. L. Inhibition of functional T cell priming and contact hypersensitivity responses by treatment with anti-secondary lyphoid chemokine andbody during hapten sensitization. J. Imunol., 164: 5207-5214, 2000.
13. Wiley, H., Gonzalez, E. B., Maki, W., Wu, M., and Hwang, S. T. Expression of CC chemokine receptor-7 (CCR7) and regional lymph node metastasis of B16 murine melanoma. J. Natl. Cancer Inst. (Bethesda), 93: 1638-1643, 2001.
14. Forster, R., Ohl. L., and Henning, G. Lessons learned from lymphocytes: CC chemokine receptor-7 involved in lymphogenic metastasis of melanoma. J. Natl. Cancer Inst. (Bethesda), 93: 1588-1589, 2001.
15. Geminder, H., Sagi-Assif, O., Goldberg, L., Meshel, T., Rechavi, G., Witz, I. P., and Ben-Baruch, A. A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma. J. Immunol., 167: 4747-4757, 2001.
16. Robledo, M. M., Bartolome, R. A., Longo, N. Rodriguez-Frade, J. M., Mellado, M., Longo, I., van Muijen, G. N., Sanchez-Mateos, P., and Teixido. J. Expression of functional chemokine receptors CXCR3 and CXCR4 on human melanoma cells. J. Biol. Chem., 276: 45098-45105, 2001.
17. Taichman, R. S., Cooper, C., Keller, E. T., Pienta, K. J., Taichman. N. S., and McCauley,L. K. Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res., 62: 1832-1837, 2002.
18. Peled, A., Petit, I., Kollet, O., Magid, M., Ponomaryov, T., Byk, T., Nagler, A., Ben-Hur. H., Many, A., Shultz, L., Lider, O., Alon. R., Zipori. D., and Lapidot, T. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science (Wash. DC), 283: 845-848, 1999.
19. Lataillade, J. J., Clay, D., Dupuy, C., Rigal. S., Jasmin, C., Bourin, P., and Le Bousse-Kerdiles, M. C. Chemokine SDF-I enhances circulating CD34(+) cell proliferation in synergy with cytokines: Possible role in progenitor survival. Blood, 95: 756-768, 2000.
20. + cells: Evidence for an autocrine/paracrine mechanism. Blood. 99: 1117-1129, 2002.
21. Fidler, I. J. Selection of successive tumour lines for metastasis. Nat. New Biol., 242: 148-149, 1973.
22. Fitzhugh. D. J., Naik, S., Caughman, S. W., and Hwang, S. T. Cutting edge: CC chemokine receptor-6 (CCR6) is essential for arrest of a subset of memory T cells on activated dermal microvascular endothelial cells under physiologic flow conditions in vitro. J. Immunol., 165: 6677-6681, 2000.
23. Murakami, T., Nakajima, T., Koyanagi, Y., Tachibana. K., Fujii, N., Tamamura, H., Yoshida, N., Waki, M., Matsumoto. A., Yoshie, O., Kishimoto, T., Yamamoto, N., and Nagasawa, T. A small molecule CXCR4 inhibitor that blocks T cell line-trophic HIV-I infection. J. Exp. Med., 186: 1389-1393, 1997.
24. Feng, Y., Broder, C. C., Kennedy. P. E., and Berger, E. A. HIV-I entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science (Wash. DC), 272: 872-877, 1996.
25. Cinamon, G., Shinder, V., and Alon, R. Shear forces promote lymphocyte migration across vascular endothelium bearing apical chemokines, Nat. Immunol., 2: 515-522, 2001.
26. Nakashima, H., Masuda, M., Murakami, T., Koyanagi, Y., Matsumoto, A., Fujii, N., and Yamamoto, N. Anti-human immunodeficiency virus activity of a novel synthetic peptide, T22 ([Tyr-5, 12, Lys-7]polyphemusin II): A possible inhibitor of virus-cell fusion. Antimicrob. Agents Chemother., 36: 1249-1255, 1992.
27. Salvucci, O., Yao, L., Villalba, S., Sajewicz, A., Pittaluga, S., and Tosato, G. Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1. Blood, 99: 2703-2711, 2002.
28. Peled, A., Kollet, O., Ponomaryov, T., Petit, I., Franitza, S., Grabovsky, V., Slav, M. M., Nagler, A., Lider, O., Alon, R., Zipori, D., and Lapidot, T. The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: Role in transendothelial/stromal migration and engraftment of NOD/SCID mice. Blood, 95: 3289-3296, 2000.
29. Kijowski, J., Baj-Krzyworzeka. M., Majka. M., Reca, R., Marquez, L. A., Christofidou-Solomidou, M., Janowska-Wieczorek, A., and Ratajczak, M. Z. The SDF-1-CXCR4 axis stimulates VEGF secretion and activates integrins but does not affect proliferation and survival in lymphohematopoietic cells. Stem Cells. 19: 453-466, 2001.
30. 1251-5-iodo-2′-deoxyuridine. J. Natl. Cancer Inst. (Bethesda), 45: 773-782, 1970.
31. Ito, S., Nakanishi, H., Ikehara, Y., Kato, T., Kasai, Y., Ito, K., Akiyama, S., Nakao, A., and Tatematsu, M. Real-time observation of micrometastasis formation in the living mouse liver using a green fluorescent protein gene-tagged rat tongue carcinoma cell line. Int. J. Cancer, 93: 212-217, 2001.
32. Doranz, B. J., Filion, L. G., Diaz-Mitoma, F., Sitar, D. S., Sahai, J., Baribaud, F., Orsini, M. J., Benovic, J. L., Cameron, W., and Doms, R. W. Safe use of the CXCR4 inhibitor ALX40-4C in humans. AIDS Res. Hum. Retroviruses. 17: 475-486, 2001.
33. Matthys, P., Hatse. S., Vermeire, K., Wuyts, A., Bridger, G., Henson, G. W., De Clercq, E., Billiau. A., and Schols, D. Amd3100, a potent and specific antagonist of the stromal cell-derived factor-I chemokine receptor cxcr4, inhibits autoimmune joint inflammation in ifn-gamma receptor-deficient mice. J. Immunol., 167: 4686-4692, 2001.
34. Tiffany, H. L., Lautens, L. L., Gao, J. L., Pease, J., Locati, M., Combadiere. C., Modi, W., Bonner, T. I., and Murphy, P. M. Identification of CCR8: A human monocyte and thymus receptor for the CC chemokine 1-309. J. Exp. Med., 186: 165-170, 1997.